Eagle Pharmaceuticals

$45.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+0.22%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell EGRX and other stocks, options, and ETFs commission-free!

About EGRX

Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ. The listed name for EGRX is Eagle Pharmaceuticals, Inc. Common Stock.

CEO
Scott L. Tarriff
Employees
108
Headquarters
Woodcliff Lake, New Jersey
Founded
2007
Market Cap
593.91M
Price-Earnings Ratio
128.89
Dividend Yield
—
Average Volume
122.29K
High Today
$46.57
Low Today
$45.50
Open Price
$46.02
Volume
111.25K
52 Week High
$56.16
52 Week Low
$33.80

EGRX Earnings

$0.00
$0.39
$0.78
$1.17
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 2, Pre-Market

You May Also Like

EWV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure